Laboratory biomarkers in the diagnosis and follow-up of treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis

References

• Lagrou K, Maertens J, Van Even E, et al. Burden of serious fungal infections in Belgium. Mycoses. 2015;58:1–5.
   PubMed Web of Science ®Google Scholar
• Greenberger PA, Bush RK, Demain JG, et al. Allergic bronchopulmonary. Aspergillosis. J Allergy Clin Immunol Pract. 2014;2(6):703–708.
   PubMed Web of Science ®Google Scholar
• Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86(4):405–414.
   PubMed Web of Science ®Google Scholar
• Chotirmall SH, Martin-Gomez MT. Aspergillus species in bronchiectasis: challenges in the cystic fibrosis and non-cystic fibrosis airways. Mycopathologia. 2018;183(1):45–59.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–873.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Aggarwal AN, et al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J Infect Public Health. 2011;4(5–6):235–243.
   PubMedGoogle Scholar
• Keown K, Abbott S, Kuzeljevic B, et al. An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosis. Pediatr Pulmonol. 2019;54(11):1787–1793.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Sehgal IS, et al. Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis. Mycoses. 2016;59(1):1–6.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Sehgal IS, Dhooria S, et al. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med. 2016;10(12):1317–1334.
   PubMed Web of Science ®Google Scholar
• Ashkenazi M, Sity S, Sarouk I, et al. Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Asthma Allergy. 2018;11:101–107.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis – state of the art. Clin Infect Dis. 2003;37(s3):S225–S264.
   PubMedGoogle Scholar
• Tracy MC, Okorie CUA, Foley EA, et al. Allergic bronchopulmonary aspergillosis. JoF. 2016;2(2):17.
   Google Scholar
• Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J. 2000;16(3):464–471.
   PubMed Web of Science ®Google Scholar
• Carsin A, Romain T, Ranque S, et al. Aspergillus fumigatus in cystic fibrosis: an update on immune interactions and molecular diagnostics in allergic bronchopulmonary aspergillosis. Allergy. 2017;72(11):1632–1642.
   PubMed Web of Science ®Google Scholar
• Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45(12):1765–1778.
   PubMed Web of Science ®Google Scholar
• Aimanianda V, Bayry J, Bozza S, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460(7259):1117–1121.
   PubMed Web of Science ®Google Scholar
• Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev. 2009;22(4):535–551.
   PubMed Web of Science ®Google Scholar
• Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol. 2009;47(s1):S331–S337.
   PubMedGoogle Scholar
• Hartl D. Immunological mechanisms behind the cystic. Med Mycol. 2009;47(s1):S183–S91.
   PubMedGoogle Scholar
• Becker KL, Gresnigt MS, Smeekens SP, et al. Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy. 2015;45(2):423–437.
   PubMed Web of Science ®Google Scholar
• Hafen GM, Hartl D, Regamey N, et al. Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serological marker in cystic fibrosis patients. Expert Rev Mol Diagn. 2009;9(2):157–164.
   PubMed Web of Science ®Google Scholar
• Kauffman HF. Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling. Front Biosci. 2003;8(5):e190–e196.
   PubMedGoogle Scholar
• Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a perplexing clinical entity. Allergy Asthma Immunol Res. 2016;8(4):282–297.
   PubMed Web of Science ®Google Scholar
• Miller PW, Hamosh A, Macek M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996;59:45–51.
   PubMed Web of Science ®Google Scholar
• Eaton TE, Weiner Miller P, Garrett JE, et al. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy. 2002;32(5):756–761.
   PubMed Web of Science ®Google Scholar
• Nguyen NLH, Pilewski JM, Celedón JC, et al. Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study. Asthma Res Prac. 2015;1:3.
   PubMedGoogle Scholar
• Kreindler JL, Steele C, Nguyen N, et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 2010;120(9):3242–3254.
   PubMed Web of Science ®Google Scholar
• Dodamani MH, Muthu V, Thakur R, et al. A randomised trial of vitamin D in acute‐stage allergic bronchopulmonary aspergillosis complicating asthma. Mycoses. 2019;62(4):320–327.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Sehgal IS, Dhooria S, et al. Vitamin D levels in asthmatic patients with and without allergic bronchopulmonary aspergillosis. Mycoses. 2018;61(6):344–349.
   PubMed Web of Science ®Google Scholar
• Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis. 1979;120(4):863–873.
   PubMed Web of Science ®Google Scholar
• Wayne C, Morgan J, Butler SM, et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the the U.S. and Canada. Pediatr Pulmonol. 1999;28:231–241.
   PubMed Web of Science ®Google Scholar
• Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest. 1999;116(3):639–646.
   PubMed Web of Science ®Google Scholar
• Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Revi. 2009;10(1):37–42. s
   PubMed Web of Science ®Google Scholar
• UK Cystic Fibrosis Trust Antibiotic Group. Antibiotic treatment for cystic fibrosis; 2002. Available from: https://www.sifc.it/wp-content/uploads/2020/09/UK_CF_Trust_Antibiotic.pdf
   Google Scholar
• Saxena P, Choudhary H, Muthu V, et al. Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis. J Allergy Clin Immunol Pract. 2021;9(1):328–335.e1.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Saxena P, Muthu V, et al. Evaluation of simpler criteria for diagnosing allergic bronchopulmonary aspergillosis complicating asthma. Front Cell Infect Microbiol. 2022;12:861866.
   PubMed Web of Science ®Google Scholar
• Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2021;147(4):1261–1268.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Sethi S, Raman DV, et al. Eight-year study of allergic bronchopulmonary aspergillosis in an indian teaching hospital. Mycoses. 2002;45(8):295–299.
   PubMed Web of Science ®Google Scholar
• Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol. 2000;18(4):181–185.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis. Chest. 2007;132(4):1183–1190.
   PubMed Web of Science ®Google Scholar
• Bhardwaj M. Approach to allergic bronchopulmonary aspergillosis (ABPA): quick review. EC Pulmonol Respir Med. 2020;9:90–101.
   Google Scholar
• Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am J Roentgenol. 1995;165(2):261–267.
   PubMed Web of Science ®Google Scholar
• Mitchell TAM, Hamilos DL, Lynch DA, et al. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma. 2000;37(1):65–72.
   PubMed Web of Science ®Google Scholar
• Refait J, Macey J, Bui S, et al. CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis. J Cystic Fibros. 2019;18(4):e31–e36.
   PubMedGoogle Scholar
• Dournes G, Berger P, Refait J, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: MR imaging of airway mucus contrasts as a tool for diagnosis. Radiology. 2017;285(1):261–269.
   PubMed Web of Science ®Google Scholar
• Kraemer R, Deloséa N, Ballinari P, et al. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 2006;174(11):1211–1220.
   PubMed Web of Science ®Google Scholar
• Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc. 2010;7(3):237–244.
   PubMedGoogle Scholar
• Agarwal R, Aggarwal AN, Gupta D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13(8):936–944.
   PubMed Web of Science ®Google Scholar
• Nikolaizik WH, Weichel M, Blaser K, et al. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med. 2002;165(7):916–921.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Maskey D, Aggarwal AN, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLOS One. 2013;8(4):e61105.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Garg M, et al. Cut-off values of serum IgE (total and A. fumigatus-specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses. 2014;57(11):659–663.
   PubMed Web of Science ®Google Scholar
• Dolen WK. IgE antibody in the serum – detection and diagnostic significance. Allergy. 2003;58(8):717–723.
   PubMed Web of Science ®Google Scholar
• CLSI. Analytical performance characteristics, quality assurance and clinical utility of immunological assays for human immunoglobulin E (IgE) antibodies of defined allergen specificities; approved guideline. 3rd ed. CLSI document I/LA20-A3. Wayne (PA): Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol. 2011;2011:843763.
   PubMedGoogle Scholar
• Agarwal R, Dua D, Choudhary H, et al. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis. Mycoses. 2017;60(1):33–39.
   PubMed Web of Science ®Google Scholar
• Hamada Y, Fukutomi Y, Nakatani E, et al. Optimal Aspergillus fumigatus and aspf1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis. Allergol Int. 2021;70(1):74–80.
   PubMed Web of Science ®Google Scholar
• Eschenhagen P, Grehn C, Schwarz C. Prospective evaluation of Aspergillus fumigatus-specific IgG in patients with cystic fibrosis. Front Cell Infect Microbiol. 2021;10:1–8.
   Web of Science ®Google Scholar
• Skov M, Pressler T, Jensen HE, et al. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax. 1999;54(1):44–50.
   PubMed Web of Science ®Google Scholar
• Delhaes L, Frealle E, Pinel C. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges. Med Mycol. 2010;48(O1):S77–S87.
   PubMedGoogle Scholar
• Li BCM, Huh SM, Prieto MD, et al. Biomarkers for the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9(5):1909–1930.
   PubMed Web of Science ®Google Scholar
• Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy. 2005;60(7):841–857.
   PubMed Web of Science ®Google Scholar
• Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52(9):1123–1129.
   PubMed Web of Science ®Google Scholar
• Hogan C, Denning D. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin Respir Crit Care Med. 2011;32(6):682–692.
   PubMed Web of Science ®Google Scholar
• Baxter CG, Dunn G, Jones AM, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(3):560–566.e10.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Sehgal IS, et al. Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis. Mycoses. 2015;58(7):408–412.
   PubMed Web of Science ®Google Scholar
• Casaulta C, Flückiger S, Crameri R, et al. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol. 2005;16(3):217–225.
   PubMed Web of Science ®Google Scholar
• Latzin P, Hartl D, Regamey N, et al. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J. 2008;31(1):36–42.
   PubMed Web of Science ®Google Scholar
• Fricker-Hidalgo H, Coltey B, Llerena C, et al. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol. 2010;17(9):1330–1336.
   PubMedGoogle Scholar
• Alghamdi NS, Barton R, Wilcox M, et al. Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis. J Med Microbiol. 2019;68(6):924–929.
   PubMed Web of Science ®Google Scholar
• Muthu V, Singh P, Choudhary H, et al. Diagnostic cutoffs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2020;8(2):579–587.
   PubMed Web of Science ®Google Scholar
• Muthu V, Sehgal IS, Dhooria S, et al. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48(9):1107–1136.
   PubMed Web of Science ®Google Scholar
• Vitte J, Ranque S, Carsin A, et al. Multivariate analysis as a support for diagnostic flowcharts in allergic bronchopulmonary aspergillosis: a proof-of-concept study. Front Immunol. 2017;8:1019.
   PubMed Web of Science ®Google Scholar
• Lukaszewicz R, Mahay G, Boyer O, et al. Medical algorithm: Aspergillus fumigatus components in the diagnosis of allergic bronchopulmonary aspergillosis. Allergy. 2022;77(1):327–330.
   PubMed Web of Science ®Google Scholar
• Oliva A, Flori P, Hennequin C, et al. Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis. J Clin Microbiol. 2015;53(1):248–254.
   PubMed Web of Science ®Google Scholar
• Richardson MD, Page ID. Aspergillus serology: have we arrived yet? Med Mycol. 2017;55(1):48–55.
   PubMed Web of Science ®Google Scholar
• Piarroux RP, Romain T, Martin A, et al. Multicenter evaluation of a novel immunochromatographic test for anti-aspergillus IgG detection. Front Cell Infect Microbiol. 2019; 9:12.
   PubMed Web of Science ®Google Scholar
• Hunter ES, Page ID, Richardson MD, et al. Evaluation of the LDBio aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis. PLOS One. 2020;15(9):e0238855.
   PubMed Web of Science ®Google Scholar
• Kwizera R, Bongomin F, Olum R, et al. Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda. PLOS One. 2021;16(5):e0252553.
   PubMed Web of Science ®Google Scholar
• Hoffmann HJ, Santos AF, Mayorga C, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015;70(11):1393–1405.
   PubMed Web of Science ®Google Scholar
• Ebo DG, Bridts CH, Mertens CH, et al. Principles, potential, and limitations of ex vivo basophil activation by flow cytometry in allergology: a narrative review. J Allergy Clin Immunol. 2021;147(4):1143–1153.
   PubMed Web of Science ®Google Scholar
• Gernez Y, Dunn, Everson C, Mitsunaga E, et al. Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens. J Cyst Fibros. 2012;11(6):502–510.
   PubMed Web of Science ®Google Scholar
• Macglashan D, Macglashan D, Hopkins J. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy. 2010;40(9):1365–1377.
   PubMed Web of Science ®Google Scholar
• Gernez Y, Waters J, Mirković B, et al. Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J. 2016;47(1):177–185.
   PubMed Web of Science ®Google Scholar
• Mirković B, Lavelle GM, Azim AA, et al. The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis. J Allergy Clin Immunol. 2016;137(2):436–443.
   PubMed Web of Science ®Google Scholar
• Katelari A, Tzanoudaki M, Noni M, et al. The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients. J Cyst Fibros. 2016;15(5):587–596.
   PubMed Web of Science ®Google Scholar
• Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI Molecular allergology user’s guide. Pediatr Allergy Immunol. 2016;27(Suppl 23):1–250.
   PubMed Web of Science ®Google Scholar
• Piarroux RP, Dubus JC, Reynaud-Gaubert M, et al. A new IgE Western blot identifies Aspergillus fumigatus sensitization and may discriminate allergic bronchopulmonary aspergillosis. Allergy. 2019;74(9):1808–1810.
   PubMed Web of Science ®Google Scholar
• Piarroux RP. Interest of Aspergillus fumigatus Western blot assay for IgE sensitization and allergic bronchopulmonary aspergillosis diagnosis. Allergy. 2018;73:215.
   Web of Science ®Google Scholar
• Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47(4):624–630.
   PubMed Web of Science ®Google Scholar
• Grunnet M, Sorensen JB. Carcinoembryonic antigen (A) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138–143.
   PubMed Web of Science ®Google Scholar
• Noguchi T, Yamamoto K, Moriyama G, et al. Evaluation of serum levels of carcinoembryonic antigen in allergic bronchopulmonary aspergillosis. J Nippon Med Sch. 2013;80(6):404–409.
   PubMed Web of Science ®Google Scholar
• Yang Y, Qiqi G, Jin Y, et al. Eosinophils may serve as A-secreting cells for allergic bronchopulmonary aspergillosis (ABPA) patients. Sci Rep. 2021;11(1):4025.
   PubMed Web of Science ®Google Scholar
• Wu G, Meng X, Zheng P, et al. Elevated serum levels of periostin in patients with allergic bronchopulmonary aspergillosis. Mycoses. 2019;62:780–789.
   PubMed Web of Science ®Google Scholar
• Matsumoto H. Role of serum periostin in the management of asthma and its comorbidities. Respir Investig. 2020;58(3):144–154.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Hebisawa A, Oguma T, et al. Evaluating serum periostin levels in allergic bronchopulmonary aspergillosis. Allergy. 2020;75(4):974–977.
   PubMed Web of Science ®Google Scholar
• Hartl D, Latzin P, Zissel G, et al. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med. 2006;173(12):1370–1376.
   PubMed Web of Science ®Google Scholar
• Zijtregtop EAM, Van Der Strate I, Beishuizen A, et al. Biology and clinical applicability of plasma thymus and activation-regulated chemokine (TARC) in classical hodgkin lymphoma. Cancers. 2021;13(4):884.
   PubMed Web of Science ®Google Scholar
• Thijs J, Krastev T, Weidinger S, et al. Biomarkers for atopic dermatitis: a systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015;15(5):453–460.
   PubMed Web of Science ®Google Scholar
• Matsumoto N, Matsumoto N, Mukae H, et al. Elevated levels of thymus and activation-regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani. Clin Exp Immunol. 2002;130(2):314–318.
   PubMed Web of Science ®Google Scholar
• Kozlova Y, Frolova E, Uchevatkina A, et al. Diagnostic markers of allergic bronchopulmonary aspergillosis in patients with severe asthma. Mycoses. 2020;63(6):596–603.
   PubMed Web of Science ®Google Scholar
• Chua JC, Douglass JA, Gillman A, et al. Galectin-10, a potential biomarker of eosinophilic airway inflammation. PLOS One. 2012;7(8):e42549.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513–10518.
   PubMed Web of Science ®Google Scholar
• Esawy MM, Baioumy SA, Ismail NA, et al. Role of circulating microRNA-132 in allergic bronchopulmonary aspergillosis: a case-control study. Immunobiology. 2021;226:152074.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen Z, Xu K, et al. Next generation sequencing for miRNA profile of spleen CD4+ T cells in the murine model of acute asthma. Epigenomics. 2018;10(8):1071–1083.
   PubMed Web of Science ®Google Scholar
• Wu C, Xu K, Wang Z, et al. A novel microRNA miR-1165-3p as a potential diagnostic biomarker for allergic asthma. Biomarkers. 2019;24(1):56–63.
   PubMed Web of Science ®Google Scholar
• Sanak M. Eicosanoid mediators in the airway inflammation of asthmatic patients: what is new? Allergy Asthma Immunol Res. 2016;8(6):481–490.
   PubMed Web of Science ®Google Scholar
• Li L, Wu J, Bian X, et al. Analysis of serum polyunsaturated fatty acid metabolites in allergic bronchopulmonary aspergillosis. Respir Res. 2020;21(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hamilton RG. Monitoring allergic patients on omalizumab with free and total serum IgE measurements. J Allergy Clin Immunol Pract. 2016;4(2):366–368.
   PubMed Web of Science ®Google Scholar
• Hamilton RG, Marcotte GV, Saini SS. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (xolair) therapy. J Immunol Methods. 2005;303(1–2):81–91.
   PubMed Web of Science ®Google Scholar
• Baker DL, Peng K, Cheu M, et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Cur Med Res Opin. 2014;30(5):913–922.
   PubMed Web of Science ®Google Scholar
• Genentech, Novartis US. Xolair FDA prescribing information; 2021. Available from: http://www.gene.com/gene/products/information/pdf/xolair-prescribing.pdf
   Google Scholar
• Strohner P, Staatz A, Sarrach D, et al. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy. Clin Chem Lab Med. 2012;50(7):1263–1269.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med. 2010;104(2):204–210.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Khan A, Aggarwal AN, et al. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern Med. 2011;50(8):855–860.
   PubMed Web of Science ®Google Scholar
• Janahi IA, Rehman A, Al-Naimi AR. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ann Thorac Med. 2017;12:74–82.
   PubMed Web of Science ®Google Scholar
• Moreira AS, Silva D, Ferreira AR, et al. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy. 2014;44(10):1210–1227.
   PubMed Web of Science ®Google Scholar
• Epps QJ, Epps KL, Zobell JT, et al. Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis. Pediatr Pulmonol. 2020;55(12):3541–3572.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Dhooria S, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2016;47(2):490–498.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018;52(3):1801159.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Dhooria S, Singh Sehgal I, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–664.
   PubMed Web of Science ®Google Scholar
• Thomson JM, Wesley A, Byrnes CA, et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol. 2006;41(2):164–170.
   PubMed Web of Science ®Google Scholar
• Cohen-Cymberknoh M, Blau H, Shoseyov D, et al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. J Cyst Fibros. 2009;8(4):253–257.
   PubMed Web of Science ®Google Scholar
• Thomas MF. Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody. J R Soc Med. 2009;102(1_suppl):49–53.
   PubMedGoogle Scholar
• Singh Sehgal I, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations. Eur Respir Rev. 2014;23(131):149–152.
   PubMedGoogle Scholar
• Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to the Research Committee of the British Thoracic Association. Br J Dis Chest. 1979;73:349–356.
   PubMedGoogle Scholar
• Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med. 2004;98(10):914–923.
   Web of Science ®Google Scholar
• Elphick HE, Southern KW. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;11:CD002204.
   PubMedGoogle Scholar
• Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342(11):756–762.
   PubMed Web of Science ®Google Scholar
• Wark PAB, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111(5):952–957.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Muthu V, Sehgal IS, et al. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2022;59(4):2101787.
   PubMed Web of Science ®Google Scholar
• Patel AR, Patel AR, Singh S, et al. Treating allergic bronchopulmonary aspergillosis: a review. Cureus. 2019;11(4):e4538.
   PubMed Web of Science ®Google Scholar
• Chishimba L, Niven RM, Cooley J, et al. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012;49(4):423–433.
   PubMed Web of Science ®Google Scholar
• Periselneris J, Nwankwo L, Schelenz S, et al. Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Antimicrob Chemother. 2019;74(6):1701–1703.
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Saez-Lacy D, Wynkoop W, et al. Successful treatment of allergic bronchopulmonary aspergillosis with isavuconazole: case report and review of the literature. Open Forum Infect Dis. 2017;4(2):ofx040.
   PubMed Web of Science ®Google Scholar
• Proesmans M, Vermeulen F, Vreys M, et al. Use of nebulized amphotericin b in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int J Pediatr. 2010;2010:1–9.
   Google Scholar
• Li JX, Fan LC, Li MH, et al. Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature. Respir Med. 2017;122:33–42.
   PubMed Web of Science ®Google Scholar
• Xolair: summary of product characteristics, Annex 1. Available from: https://www.ema.europa.eu/en/documents/product-information/xolair-epar-product-information_en.pdf.
   Google Scholar
• Eraso IC, Sangiovanni S, Morales EI, et al. Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Ther Adv Respir Dis. 2020;14:1753466620961648.
   Web of Science ®Google Scholar
• Jat KR, Walia DK, Khairwa A. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2018;3(3):CD010288.
   PubMedGoogle Scholar
• Tolebeyan A, Mohammadi O, Vaezi Z, et al. Mepolizumab as possible treatment for allergic bronchopulmonary aspergillosis: a review of eight cases. Cureus. 2020;2:e9684.
   Google Scholar
• Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest. 1999;116(6):1665–1668.
   PubMed Web of Science ®Google Scholar
• Currie DC, Lueck C, Milburn HJ, Harvey C, et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax. 1990;45(6):447–450.
   PubMed Web of Science ®Google Scholar
• Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax. 1987;42(1):26–31.
   PubMed Web of Science ®Google Scholar
• Joest M. Allergic bronchopulmonary aspergillosis (ABPA) in an atopic patient with difficult-to-expectorate airway secretions. Allergol Select. 2021;5:157–161.
   PubMedGoogle Scholar
• Agarwal R, Garg M, Aggarwal AN, et al. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med. 2012;106(7):942–947.
   PubMed Web of Science ®Google Scholar
• Skov M, Høiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy. 2002;57(8):723–728.
   PubMed Web of Science ®Google Scholar
• Ramonell RP, Lee FEH, Swenson C, et al. Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series. J Allergy Clin Immunol Pract. 2020;8(2):742–743.
   PubMed Web of Science ®Google Scholar
• Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1984;74(1):68–71.
   PubMed Web of Science ®Google Scholar
• Mahdavinia M, Grammer LC. Management of allergic bronchopulmonary aspergillosis: a review and update. Ther Adv Respir Dis. 2012;6(3):173–187.
   PubMed Web of Science ®Google Scholar
• Parisi GF, Portale A, Papale M, et al. Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: case reports and literature review. J Allergy Clin Immunol Pract. 2019;7(5):1636–1638.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Powell G, Niven R, et al. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosisr. Respirology. 2009;14(8):1121–1127.
   PubMed Web of Science ®Google Scholar
• Voskamp AL, Gillman A, Symons K, et al. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2015;3(2):192–199.
   PubMed Web of Science ®Google Scholar